跳到主要內容

Fennec Pharmaceuticals Inc.

FENC
交易所
Nasdaq
產業
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

近 90 天,Fennec Pharmaceuticals Inc. 內部人申報 0 筆公開市場買進、4 筆賣出;2026 年第 2 季末有 105 家機構在 13F 申報持有,市值合計 $1.75 億;沒有大師持有。

持有 FENC 5% 以上的大股東

最新一份 Schedule 13D 或 13G 申報持有 Fennec Pharmaceuticals Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。

持有 FENC 5% 以上的大股東
持有人最新表單持股變化首次申報最新申報原文
Rosalind Advisors, Inc.13G/A9.60%股數 332.1 萬+0.80 個百分點原本 8.80%2025/11/134 份2026/8/13SEC
Sonic Fund II, L.P.13G/A8.20%股數 280.0 萬–2021/2/163 份2026/2/17SEC
Hirschman Orin13G/A7.10%股數 249.9 萬+1.40 個百分點原本 5.70%2026/4/282 份2026/10/19SEC
Solas Capital Management, LLC13G/A5.40%股數 188.9 萬−1.80 個百分點原本 7.20%2024/2/145 份2026/8/14SEC

持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。

13D 與 13G 申報

Fennec Pharmaceuticals Inc. 的 23 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。

FENC 的 Schedule 13D、13G 申報
申報時間(美東)申報人表單持股變化事件日原文
2026/10/1908:13 ETHirschman Orin等 2 位13G/A7.10%股數 249.9 萬+1.40 個百分點原本 5.70%2026/9/30SEC
2026/8/1416:05 ETSouthpoint Capital Advisors LP等 6 位13G/A0.00%股數 0−8.00 個百分點原本 8.00%低於 5%2026/6/30SEC
2026/8/1410:38 ETSolas Capital Management, LLC等 2 位13G/A5.40%股數 188.9 萬−1.80 個百分點原本 7.20%2026/6/30SEC
2026/8/1310:31 ETRosalind Advisors, Inc.等 4 位13G/A9.60%股數 332.1 萬+0.80 個百分點原本 8.80%2026/6/30SEC
2026/5/1510:58 ETSolas Capital Management, LLC等 2 位13G/A7.20%股數 248.2 萬−1.00 個百分點原本 8.20%2026/3/31SEC
2026/5/1414:50 ETRosalind Advisors, Inc.等 4 位13G/A8.80%股數 304.2 萬−1.00 個百分點原本 9.80%2026/3/31SEC
2026/4/2816:15 ETHirschman Orin等 2 位13G5.70%股數 198.2 萬新申報2026/3/31SEC
2026/2/1710:39 ETSonic Fund II, L.P.等 3 位13G/A8.20%股數 280.0 萬–2025/12/31SEC
2026/2/1113:58 ETRosalind Advisors, Inc.等 4 位13G/A9.80%股數 274.7 萬+2.30 個百分點原本 7.50%2025/12/31SEC
2026/1/1417:00 ETSouthpoint Capital Advisors LP等 6 位13G/A8.00%股數 274.5 萬–2025/12/31SEC
2025/11/1316:08 ETRosalind Advisors, Inc.等 4 位13G7.50%股數 207.7 萬新申報2025/9/30SEC
2025/2/1413:00 ETSolas Capital Management, LLC等 2 位13G/A8.20%股數 225.1 萬+1.20 個百分點原本 7.00%2024/12/31SEC
2025/2/1412:06 ETDG Capital Management, LLC等 3 位13G/A4.10%股數 111.5 萬–低於 5%2024/12/31SEC
2024/11/1413:58 ETSolas Capital Management, LLC等 2 位13G/A7.00%股數 192.4 萬–2024/9/30SEC
2024/11/12DG Capital Management, LLC13G/A舊制–––SEC
2024/6/27DG Capital Management, LLC13G舊制–新申報–SEC
2024/2/14Solas Capital Management, LLC13G舊制–新申報–SEC
2023/2/14Sonic GP LLC13G/A舊制–––SEC
2022/2/14Sonic Fund II, L.P.13G/A舊制–––SEC
2022/2/11Avoro Capital Advisors LLC13G/A舊制–––SEC
2021/2/16Sonic Fund II, L.P.13G舊制–新申報–SEC
2021/2/12Southpoint Capital Advisors LP13G/A舊制–––SEC
2021/2/12Avoro Capital Advisors LLC13G/A舊制–––SEC

Form 144:內部人預計賣出

高階主管、董事與其他關係人預計賣出 Fennec Pharmaceuticals Inc. 股票的 60 份通知,由新到舊。

FENC 的 Form 144
申報時間(美東)賣方預計賣出股數市值預計賣出日券商原文
2026/9/1516:06 ETMarco Brughera董事1.55 萬$16.0 萬2026/9/1510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/9/116:13 ETRostislav Raykov前董事1.00 萬$12.1 萬2026/9/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/3116:07 ETPierre S Sayad高階主管1.20 萬$14.6 萬2026/8/31Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/2716:20 ETRobert Andrade高階主管7.50 萬$88.4 萬2026/8/2710b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/8/317:05 ETRostislav Raykov前董事1.00 萬$9.58 萬2026/8/310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/7/116:29 ETRostislav Raykov董事9,599$10.0 萬2026/7/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/6/116:14 ETRostislav Raykov董事9,747$9.38 萬2026/6/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/1116:16 ETChris A Rallis董事8,346$5.88 萬2026/5/1110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/5/116:15 ETRostislav Raykov董事1.08 萬$6.98 萬2026/5/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/4/116:38 ETRostislav Raykov董事1.09 萬$6.91 萬2026/4/110b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/3/217:07 ETRostislav Raykov董事1.01 萬$8.44 萬2026/3/210b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/2/216:32 ETRostislav Raykov董事1.03 萬$8.03 萬2026/2/210b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2026/1/216:19 ETRostislav Raykov董事1.03 萬$7.85 萬2026/1/210b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/12/517:13 ETRostislav Raykov董事1.00 萬$7.54 萬2025/12/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/11/516:28 ETRostislav Raykov董事1.00 萬$8.11 萬2025/11/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/10/1016:02 ETChris A Rallis董事1,775$1.64 萬2025/10/1010b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/10/616:27 ETRostislav Raykov董事1.00 萬$9.79 萬2025/10/610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/9/416:37 ETRostislav Raykov董事1.00 萬$8.92 萬2025/9/410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/8/516:14 ETRostislav Raykov董事1.00 萬$8.09 萬2025/8/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/7/314:01 ETRostislav Raykov董事1.00 萬$8.61 萬2025/7/310b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/6/516:31 ETRostislav Raykov董事1.00 萬$7.78 萬2025/6/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/5/1617:21 ETRaykov Rosty董事1.67 萬$10.0 萬2025/5/16Morgan Stanley Smith Barney LLC Executive ServicesSEC
2025/5/516:01 ETRostislav Raykov董事1.00 萬$6.31 萬2025/5/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/4/416:12 ETRostislav Raykov董事1.00 萬$5.25 萬2025/4/410b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
2025/3/516:29 ETRostislav Raykov董事1.00 萬$6.79 萬2025/3/510b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC

只列最新的 25 份。看 FENC 近 12 個月的全部通知